Physician profile
Elena Klimenko
NPI 1134367709
$1,172.42
in general payments reported to CMS, 2019-2025
10 companies · $193 in 2025
The $193 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $103 · 2023: $388 · 2024: $488 · 2025: $193.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,069.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,069.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $404.54 | 2023-2025 | Trelegy Ellipta, Rotarix, Pediarix |
| Merck Sharp & Dohme LLC | $265.95 | 2022-2025 | Verquvo, Gardasil 9, Vaxelis |
| Bayer Healthcare Pharmaceuticals INC. | $238.19 | 2022-2025 | |
| Hologic Sales and Service, LLC | $75.44 | 2023-2025 | Aptima, Thinprep 2000 Processor |
| Lilly USA, LLC | $75.38 | 2024 | Mounjaro, Zepbound, Jardiance |
| Sanofi Pasteur INC. | $40.92 | 2022-2024 | |
| Amgen INC. | $20.86 | 2023 | Otezla, Repatha |
| Novartis Pharmaceuticals Corporation | $20.70 | 2023 | |
| Mylan Specialty L.P. | $16.87 | 2023 | Yupelri |
| Xeris Pharmaceuticals, INC. | $13.57 | 2025 | Gvoke Hypopen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elena Klimenko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.